Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03105466
Collaborator
(none)
50
1
1
48
1

Study Details

Study Description

Brief Summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis.

Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Deep anterior lamellar keratoplasty
  • Device: Acellular Porcine Cornea
  • Drug: Tacrolimus eye drops
  • Drug: Tobradex eyedrops
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea
Study Start Date :
Feb 1, 2016
Anticipated Primary Completion Date :
Feb 1, 2020
Anticipated Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acellular porcine cornea group

Participants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea

Procedure: Deep anterior lamellar keratoplasty
Deep anterior lamellar keratoplasty using acellular porcine cornea; 0.05%Tacrolimus eye drops, four times a day for at least one year; 0.3% Tobradex eyedrops, four times-one times a day for one year.

Device: Acellular Porcine Cornea

Drug: Tacrolimus eye drops

Drug: Tobradex eyedrops

Outcome Measures

Primary Outcome Measures

  1. the changes of Best corrected visual acuity [Before surgery, 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

Secondary Outcome Measures

  1. the changes of visual contrast sensitivity [Before surgery, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

  2. the changes in the transparency of graft [1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

    using Slit lamp microscopic evaluation

  3. The changes in corneal thickness depth [1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

    using anterior segmental OCT

  4. The changes in corneal nerve regeneration [1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

    using Confocal microscopy

  5. The changes of depression and anxiety status [Before surgery, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery]

    Using Self-Rating Depression Scale (SDS) and Self-Rating Anxiaty Scale (SAS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

corneal diseases not involving the endothelial layer

Exclusion Criteria:
  • corneal diseases involving the endothelial layer

  • allergic to pig tissue

  • do not accept xenotransplantation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongshan Ophthalmic Center, Sun Yat-Sen University Guangzhou Guangdong China 510080

Sponsors and Collaborators

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jin Yuan, Professor, Zhongshan Ophthalmic Center, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT03105466
Other Study ID Numbers:
  • 2016021
First Posted:
Apr 10, 2017
Last Update Posted:
Apr 10, 2017
Last Verified:
Apr 1, 2017
Keywords provided by Jin Yuan, Professor, Zhongshan Ophthalmic Center, Sun Yat-sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 10, 2017